InvestorsHub Logo
Followers 828
Posts 119319
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 6638

Thursday, 05/04/2023 11:00:10 AM

Thursday, May 04, 2023 11:00:10 AM

Post# of 6709
ABUS 1Q23 results—3/31/23 cash=$178.5M:

https://www.globenewswire.com/news-release/2023/05/04/2661394/14025/en/Arbutus-Reports-First-Quarter-2023-Financial-Results-and-Corporate-Update.html

ABUS still expects to start a phase-1 trial for AB-343, a SARS-CoV-2 protease inhibitor, in 2H23.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News